GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,891,000 | -11.4% | 709,630 | -11.3% | 0.75% | +0.9% |
| Q1 2022 | $34,865,000 | -8.6% | 800,397 | -7.5% | 0.75% | -10.2% |
| Q4 2021 | $38,141,000 | +14.7% | 864,891 | -0.6% | 0.83% | +15.2% |
| Q3 2021 | $33,261,000 | -6.7% | 870,490 | -2.8% | 0.72% | -8.8% |
| Q2 2021 | $35,652,000 | +13.3% | 895,335 | +3.5% | 0.79% | +6.3% |
| Q1 2021 | $31,470,000 | +11.9% | 865,277 | +14.0% | 0.74% | +2.9% |
| Q4 2020 | $28,120,000 | +2.6% | 759,162 | +4.3% | 0.72% | -23.5% |
| Q3 2020 | $27,395,000 | -28.5% | 727,808 | -22.5% | 0.95% | -18.8% |
| Q2 2020 | $38,301,000 | -19.1% | 938,966 | -24.8% | 1.17% | -29.6% |
| Q1 2020 | $47,315,000 | -33.2% | 1,248,743 | -17.2% | 1.66% | -1.8% |
| Q4 2019 | $70,879,000 | +3.0% | 1,508,383 | -6.4% | 1.69% | -5.2% |
| Q3 2019 | $68,808,000 | -7.3% | 1,612,195 | -13.1% | 1.78% | +7.6% |
| Q2 2019 | $74,206,000 | -14.9% | 1,854,212 | -11.1% | 1.65% | -18.4% |
| Q1 2019 | $87,149,000 | +11.7% | 2,085,398 | +2.1% | 2.02% | +1.8% |
| Q4 2018 | $78,053,000 | -13.6% | 2,042,742 | -9.2% | 1.99% | -2.5% |
| Q3 2018 | $90,344,000 | -4.4% | 2,249,052 | -4.1% | 2.04% | -4.2% |
| Q2 2018 | $94,516,000 | +1.2% | 2,344,725 | -1.9% | 2.13% | +6.9% |
| Q1 2018 | $93,356,000 | +16.3% | 2,389,464 | +5.6% | 1.99% | +22.8% |
| Q4 2017 | $80,267,000 | -7.3% | 2,262,946 | +6.1% | 1.62% | -7.8% |
| Q3 2017 | $86,590,000 | -40.3% | 2,132,764 | -36.6% | 1.76% | -23.3% |
| Q2 2017 | $144,941,000 | +2.2% | 3,361,346 | -0.1% | 2.29% | +8.9% |
| Q1 2017 | $141,817,000 | +16.9% | 3,363,788 | +6.8% | 2.10% | +15.6% |
| Q4 2016 | $121,292,000 | -20.2% | 3,149,621 | -10.7% | 1.82% | -20.1% |
| Q3 2016 | $152,062,000 | -16.9% | 3,525,668 | -16.5% | 2.28% | -18.5% |
| Q2 2016 | $183,090,000 | +0.9% | 4,224,506 | -5.6% | 2.80% | +7.8% |
| Q1 2016 | $181,437,000 | +4.5% | 4,474,409 | +4.0% | 2.60% | +2.2% |
| Q4 2015 | $173,627,000 | -3.4% | 4,303,030 | -7.9% | 2.54% | -3.4% |
| Q3 2015 | $179,680,000 | +0.0% | 4,673,082 | +8.3% | 2.63% | +14.1% |
| Q2 2015 | $179,662,000 | +0.4% | 4,313,622 | +11.2% | 2.30% | -6.6% |
| Q1 2015 | $179,019,000 | +27.6% | 3,879,073 | +18.2% | 2.46% | +24.6% |
| Q4 2014 | $140,263,000 | -10.7% | 3,281,780 | -3.9% | 1.98% | -5.0% |
| Q3 2014 | $157,021,000 | +17.4% | 3,415,717 | +36.6% | 2.08% | +28.8% |
| Q2 2014 | $133,703,000 | +15.6% | 2,500,048 | +15.5% | 1.62% | +10.8% |
| Q1 2014 | $115,635,000 | +1.0% | 2,164,241 | +0.9% | 1.46% | +3.2% |
| Q4 2013 | $114,546,000 | +20.4% | 2,145,461 | +13.1% | 1.41% | +15.4% |
| Q3 2013 | $95,158,000 | -1.4% | 1,896,714 | -1.8% | 1.22% | +1.3% |
| Q2 2013 | $96,539,000 | +3.1% | 1,931,938 | -3.2% | 1.21% | +9.3% |
| Q1 2013 | $93,615,000 | +0.3% | 1,995,632 | -7.1% | 1.11% | +1.2% |
| Q4 2012 | $93,375,000 | – | 2,148,044 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |